Schedule 13D ownership disclosure
KYTHERA BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 501570105
Event date: 2015-08-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-285023
- Form type
- SC 13D
- Filer
- Allergan plc
- CIK
- CIK 1578845
- Filed
- Aug 10, 2015
- Reporting period
- Aug 04, 2015
- Description
- Schedule 13D beneficial ownership